Parenteral versus oral route increases paracetamol efficacy

被引:55
作者
Jarde, O
Boccard, E
机构
[1] Hop Nord, Dept Orthopaed Surg, Amiens, France
[2] Labs UPSA, Rueil Malmaison, France
关键词
D O I
10.2165/00044011-199714060-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The analgesic efficacy and tolerability of parenteral versus oral paracetamol 1g were compared in 323 patients immediately after a hallux valgus plasty performed with local anaesthesia (31 men, 292 women, mean age 52 years). Using a multicentre, double-blind, double-placebo, randomised, parallel-group design, the effects of a single dose of propacetamol (PR) 2g [= paracetamol (PA) 1g], oral PA 1g and placebo (PL) were compared in the recovery room 5 hours (mean) after surgery in three parallel groups of patients with at least moderate pain on a 5-point verbal scale. Efficacy was assessed on pain scores rated on a 5-point verbal scale before administration (T0) and 0.25, 0.5, 0.75, 1, 2, 3, 4, 5 and 6 hours after administration and with an overall efficacy 5-point verbal score. Any adverse effects were recorded throughout the duration of the study. PR was statistically superior to PL on pain intensity difference (PID) from T30 minutes to T6 hours (Dunnett test), on maximum pain intensity difference (MAXPID) [p < 0.05] and summed pain intensity difference (SPID) [p < 0.05]. PA was statistically superior to PL at T1, T2, T4, T5 hours (Dunnett test), on MAXPID (p < 0.05) and SPID (p < 0.10). PR was statistically superior to PA on PID from T30 minutes to T4 hours, on MAXPID (p < 0.03) and SPID (p < 0.01). Overall efficacy was found by the patients to be superior with PR vs PA (p < 0.01), PR vs PL (p < 0.05), and PA vs PL (p < 0.10). The remedication time was significantly different between the three groups (p < 0.05). 10 patients experienced 1 adverse effect, PR: 3 (injection site pain, headache, vomiting), PA: 6 [nausea, tremor, injection site pain (3), malaise], PL: 1 (injection site pain). In conclusion, PR 2g (i.e. PA 1g) provided a significantly greater and longer analgesic effect than the same dosage in oral form.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 31 条
  • [1] ANG ET, 1990, EUR J PAIN, V11, P137
  • [2] PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF PARACETAMOL AFTER A SINGLE INTRAVENOUS DOSE OF PROPACETAMOL
    BANNWARTH, B
    NETTER, P
    LAPICQUE, F
    GILLET, P
    PERE, P
    BOCCARD, E
    ROYER, RJ
    GAUCHER, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) : 79 - 81
  • [3] BENEDETTI C, 1984, ADV PAIN RES THER, V7, P373
  • [4] Brown CR, 1990, PHARMACOTHERAPY, V10, p116S
  • [5] DELACROIX P, 1985, SEM HOP PARIS, V61, P2739
  • [6] THE MORPHINE-SPARING EFFECT OF PROPACETAMOL IN ORTHOPEDIC POSTOPERATIVE PAIN
    DELBOS, A
    BOCCARD, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (04) : 279 - 286
  • [7] DEMARNEFFE R, 1985, COMPTE RENDUS THER P, V29, P23
  • [8] TOLERANCE AND PHARMACOKINETICS OF PROPACETAMOL, A PARACETAMOL FORMULATION FOR INTRAVENOUS USE
    DEPRE, M
    VANHECKEN, A
    VERBESSELT, R
    TJANDRAMAGA, TB
    GERIN, M
    DESCHEPPER, PJ
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (06) : 259 - 262
  • [9] FARHAT F, 1995, CAH ANESTHESIOL, V4, P351
  • [10] FARKAS JC, 1992, CURR THER RES CLIN E, V51, P19